BIRC5 and cancer: Thus, our observations suggest a novel function of the IFN-γ signaling pathway in maintaining CTL persistence and might aid in designing survivin and ifi202-based strategies to maintain CTL persistence to enhance CTL function in cancer immunotherapy.